Acute effects of blood transfusion on growth hormone and insulin-like growth factor-1 levels in children with thalassemia

Hormone Research in Paediatrics

Volumn 75, Issue 4, 2011, Pages 240-245

  Mahachoklertwattana, Pat ^a   Yimsumruay, Titiya ^a   Poomthavorn, Preamrudee ^a   Chuansumrit, Ampaiwan ^a   Khlairit, Patcharin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anemia; Growth hormone; Insulin like growth factor 1; Thalassemia; Transfusion

Indexed keywords

CLONIDINE; DEFEROXAMINE; FERRITIN; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HEMATOCRIT; HORMONE RELEASE; HUMAN; INSULIN TOLERANCE TEST; IRON CHELATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROVOCATION TEST; SCHOOL CHILD;

ADOLESCENT; ANEMIA; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CLONIDINE; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DISORDERS; HEMATOCRIT; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KINETICS; LIVER; MALE; PITUITARY GLAND;

EID: 79953648886     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000321189     Document Type: Article

References (28)

1. Low LC: Growth of children with beta-thalassemia major. Indian J Pediatr 2005; 72: 159-164.
2. Rund D, Rachmilewitz E: Β-Thalassemia. N Engl J Med 2005; 353: 1135-1146.
3. Theodoridis C, Ladis V, Papatheodorou A: Growth and management of short stature in thalassemia major. J Pediatr Endocrinol Metab 1998; 11(suppl 3):835-844.
4. Grundy RG, Wood KA, Savage MO, Evan JPM: Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child 1994; 74: 128-132. (Pubitemid 24261115)
5. De Sanctis V: Growth and puberty and its management in thalassemia. Horm Res 1992; 58(suppl 1):72-79.
6. De Sanctis V, Eleftheriou A, Malaventura C: Prevalence of endocrine complications and short stature in patients with thalassemia major: a multicenter study by Thalassemia International Federation. Pediatr Endocrinol Rev 2004; 2(suppl 2):249-255.
7. Karamifar H, Karimi M, Amirhakimi G, Shabatialaei M, De Sanctis V: Reduced insulin- like growth factor I concentrations in iron-overloaded beta thalassaemic patients with normal growth hormone secretion and liver function. Pediatr Endocrinol Rev 2004; 2(suppl 2):256-258.
8. Moayeri H, Oloomi Z: Prevalence of growth and pubertal failure with respect to growth hormone and gonadotropins secretion in β- thalassemia major. Arch Iran Med 2006; 9: 329-334. (Pubitemid 44803573)
9. Chrysis DC, Alexandrides TK, Koromantzou E, Georgopoulos N, Vassilakos P, Kiess W, Kratsch J, Beratis NG, Spiliotis BE: Novel application of IGF-1 and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with β-thalassemia. Clin Endocrinol 2001; 54: 253-259. (Pubitemid 32193528)
10. Scacchi M, Danesi L, Cattaneo A, Valassi E, Giraldi FP, Argento C, D'Angelo E, Mirra N, Carnelli V, Zanaboni L, Tampieri B, Cappellini MD, Cavagnini F: Bone demineralization in adult thalassemic patients: contribution of GH and IGF-1 at different skeletal sites. Clin Endocrinol 2008; 69: 202-207. (Pubitemid 352009023)
11. Low LCK, Postel-Vinay MC, Kwan EYW, Cheung PT: Serum growth hormone (GH) binding protein, IGF-1 and IGFBP-3 in patients with β-thalassemia major and the effect of GH treatment. Clin Endocrinol 1998; 48: 641-646. (Pubitemid 28253002)
12. Katzos G, Papakostantinou-Anthanasiadou E, Athanasiou-Metaxa M, Harsoulis F: Growth hormone treatment in short children with beta-thalassemia major. J Pediatr Endocrinol Metab 2000; 13: 163-170. (Pubitemid 30117211)
13. Wu KH, Tsai FJ, Peng CT: Growth hormone (GH) deficiency in patients with β-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol 2003; 82: 637-640. (Pubitemid 37407496)
14. Geffner ME, Karlsson H: Use of recombinant human growth hormone in children with thalassemia. Horm Res 2009; 71(suppl 1):46-50.
15. Isguven P, Arslanoglu I, Erol M, Yildiz M, Adal E, Erguven M: Serum levels of ghrelin, leptin, IGF-I, IGFBP-3, insulin, thyroid hormones and cortisol in prepubertal children with iron deficiency. Endocr J 2007; 54: 985-990. (Pubitemid 351346783)
16. Sheashaa HA, Khilil A, Aarman MM, El- Shahat HE, Selim A, El-Gawad SS: Correction of hemodialysis anemia is associated with significant increase in serum concentration of IGF-I in patients treated with erythropoietin: a randomized controlled study. Int Urol Nephrol 2005; 37: 153-158. (Pubitemid 41236262)
17. Ceppi A, Mullis PE, Eggenberger E, Blum JW: Growth hormone concentration and disappearance rate, insulin-like growth factors I and II and insulin levels in iron-deficient veal calves. Ann Nutr Metab 1994; 38: 281-286.
18. Luporini SM, Bendit I, Manhani R, Bracco OL, Manzella L, Giannella-Neto D: Growth hormone and insulin-like growth factor-1 axis and growth of children with different sickle cell anemia haplotypes. J Pediatr Hematol Oncol 2001; 23: 357-363. (Pubitemid 32845662)
19. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A, Rajatanavin R: Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with β-thalassemia disease. Clin Endocrinol 2003; 58: 273-279. (Pubitemid 36308114)
20. La Rosa C, De Sanctist V, Mangiagli A, Mancuso M, Guardabasso V, Galati MC, Caruso- Nicoletti M: Growth hormone secretion in adult patients with thalassemia. Clin Endocrinol 2005; 62: 667-671. (Pubitemid 40825935)
21. Soliman A, eIZalabany M, Amer M, Ansari BM: Growth and puberty development in transfusion-dependent children and adolescents with thalassemia major and sickle cell disease. J Trop Pediatr 1999; 45: 23-30. (Pubitemid 29094914)
22. Soliman A, Banna N, Ansari BM: GH response to provocation and circulating IGF-1 and IGF-binding protein-3 concentrations, the IGF-1 generation test and clinical response to GH therapy in children with β- thalassemia. Eur J Pediatr 1998; 138: 394-400. (Pubitemid 28179369)
23. Department of Health, Ministry of Public Health, Thailand: Reference for weight, height and nutritional indices in Thais aged 1 day to 19 years. Bangkok, Department of Health, Ministry of Public Health, Thailand, 2000.
24. Winichagoon P, Fucharoen S, Chen P, Wasi P: Genetic factors affecting clinical severity in β-thalassemia syndromes. J Pediatr Hematol Oncol 2000; 22: 573-580.
25. Xu S, Gu X, Pan H, Zhu H, Gong F, Li Y, Xing Y: Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence. Endocr J 2010; 57: 221-228.
26. Bernstein D, Jesper JR, Rosenfeld RG, Hinz RL: Decrease serum insulin-like growth factor- 1 associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest 1992; 89: 1128-1132.
27. Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N: Serum IGF-1 and IGFBP-3 and growth hormone levels in children with congenital heart diseases: relationship with nutritional status, cyanosis and left ventricular functions. Neuroendocrinol Lett 2007; 28: 279-283. (Pubitemid 47045772)
28. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F: Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996; 81: 3323-3327. (Pubitemid 26296210)